Company Filing History:
Years Active: 2010
Title: The Innovative Contributions of Serena Landini
Introduction
Serena Landini is a prominent inventor based in Columbus, OH (US). She has made significant contributions to the field of cancer research through her innovative work on selective aromatase modulators. Her research focuses on developing compounds that can effectively suppress aromatase activity in cancer cells, particularly in breast cancer.
Latest Patents
Serena Landini holds a patent for "Sulfonanilide analogs as selective aromatase modulators (SAMs)." This patent describes compounds and methods that suppress aromatase activity expression in cancer cells. The compounds are characterized by specific formulas where various groups can be substituted, including alkyl, cycloalkyl, haloalkyl, aryl, and others. The patent also details small molecule selective aromatase inhibitors with a molecular weight of less than 500 g/mol, and methods for administering these inhibitors to patients in need of treatment.
Career Highlights
Serena Landini is affiliated with The Ohio State University, where she conducts her research and contributes to the academic community. Her work has garnered attention for its potential impact on cancer treatment, particularly in improving therapeutic options for patients with breast cancer.
Collaborations
Serena has collaborated with notable colleagues such as Robert Brueggemeier and Bin Su. These collaborations have further enhanced her research and contributed to the advancement of knowledge in the field of cancer therapeutics.
Conclusion
Serena Landini's innovative work in developing selective aromatase modulators represents a significant advancement in cancer research. Her contributions have the potential to improve treatment options for patients, showcasing the importance of innovation in the medical field.